Enveric BiosciencesENVB
13F holders, Q1 2026 (March 31)11holders
2new positions
2sold out
$1.94avg. 13F price*
At the end of Q1 2026, 11 institutions reported holding Enveric Biosciences Inc. (ENVB) in their 13F filings, unchanged from Q4 2025. 2 opened new positions and 2 sold out. The largest holders were Geode Capital Management, LLC ($62K), AdvisorShares Investments LLC ($33K) and UBS Group AG ($7K).
- Company
- Enveric Biosciences Inc.
- CUSIP
- 29405E505
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $64K |
| Exits | 2 | $8K |
All 13F filers, Q4 2025 → Q1 2026: 33,900 shares bought and 3,095 shares sold, net +30,805 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Geode Capital Management, LLC | 0.00% | New | 32,149 | $62K |
| AdvisorShares Investments LLC | 0.01% | No change | 16,974 | $33K |
| UBS Group AG | 0.00% | Add +24.8% | 3,612 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -42.5% | 1,103 | $2K |
| Jones Financial Companies LLLP | 0.00% | New | 1,000 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +69.4% | 83 | $161 |
| BlackRock, Inc. | 0.00% | No change | 51 | $99 |
| Wells Fargo & Company | 0.00% | No change | 1 | $2 |
| Danske Bank A/S | 0.00% | No change | 1 | $2 |
| National Bank of Canada | 0.00% | No change | 1 | $2 |
| Group One Trading LLC | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is ENVB's weight in each manager's 13F, not the share of Enveric Biosciences Inc. the manager owns.